| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 250.91B | 259.15B | 243.05B | 225.87B | 236.33B | 229.51B |
| Gross Profit | 35.80B | 36.22B | 34.68B | 32.35B | 32.07B | 37.23B |
| EBITDA | 8.06B | 7.96B | 7.30B | 7.65B | 7.10B | 9.44B |
| Net Income | 3.17B | 2.59B | 2.87B | 4.20B | 3.78B | 4.48B |
Balance Sheet | ||||||
| Total Assets | 170.32B | 173.47B | 171.04B | 161.31B | 156.72B | 157.92B |
| Cash, Cash Equivalents and Short-Term Investments | 24.67B | 23.82B | 30.07B | 41.77B | 37.42B | 33.11B |
| Total Debt | 46.41B | 43.99B | 41.99B | 40.97B | 46.64B | 52.08B |
| Total Liabilities | 108.82B | 108.31B | 109.37B | 104.33B | 105.33B | 109.38B |
| Stockholders Equity | 56.03B | 59.44B | 56.23B | 52.98B | 48.00B | 45.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.89B | -9.04B | 6.92B | 10.50B | 171.00M |
| Operating Cash Flow | 0.00 | -3.20B | -4.93B | 10.10B | 12.96B | 1.73B |
| Investing Cash Flow | 0.00 | -4.58B | -7.52B | 614.00M | -2.34B | -675.00M |
| Financing Cash Flow | 0.00 | 370.00M | 45.00M | -6.62B | -5.98B | 4.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥43.81B | 9.16 | ― | 3.87% | 1.79% | -12.61% | |
77 Outperform | ¥35.21B | 7.30 | ― | 1.78% | 4.70% | 66.89% | |
74 Outperform | ¥74.62B | 14.81 | ― | 3.17% | 4.65% | 5.17% | |
73 Outperform | ¥52.36B | 9.93 | ― | 3.00% | 5.40% | 8.39% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥146.79B | 9.32 | ― | 2.42% | 8.46% | -3.62% | |
49 Neutral | ¥22.02B | 8.36 | ― | 3.55% | 6.62% | -9.95% |